Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX)’s traded shares stood at 55.87 million during the latest session, with the company’s beta value hitting 1.28. At the last check today, the stock’s price was $1.55, to imply an increase of 19.23% or $0.25 in intraday trading. The BDRX share’s 52-week high remains $42.50, putting it -2641.94% down since that peak but still an impressive 28.39% since price per share fell to its 52-week low of $1.11.

Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) trade information

After registering a 19.23% upside in the latest session, Biodexa Pharmaceuticals Plc ADR (BDRX) has traded red over the past five days. The 5-day price performance for the stock is 19.23%, and 9.15% over 30 days. With these gigs, the year-to-date price performance is -61.73%.

BDRX Dividends

Biodexa Pharmaceuticals Plc ADR has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Going by data provided on Mar 31, 2025 , Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund holds roughly 78.0 shares. This is just over 0.00% of the total shares, with a market valuation of $121.0